Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (101-110 of 303) with videos related to

Pageof 31
Sort By:
Antiviral Therapy|October 15, 2016
Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacityNicholas T Funderburg, Dihua Xu, Martin P Playford, et al.
AIDS Research and Therapy|April 14, 2005
Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimenHeather A Baird, Andre J Marozsan, Michael M Lederman, et al.
AIDS (London, England)|May 11, 2002
HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigensHernan Valdez, Nicole L Carlson, Anthony B Post, et al.
Pediatric Research|January 20, 2012
Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurityMaricruz Crespo, Denise G Martinez, Adam Cerissi, et al.
The Journal of Infectious Diseases|January 9, 2018
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral TherapyKonstantia Angelidou, Peter W Hunt, Alan L Landay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infectionDonald D Anthony, Nicole L Yonkers, Anthony B Post, et al.
Blood|October 24, 2002
Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxicDong Zhang, Premlata Shankar, Zhan Xu, et al.
Clinical Immunology (Orlando, Fla.)|November 15, 2008
The effect of aging on T-regulatory cell frequency in HIV infectionAllan R Tenorio, John Spritzler, Jeffrey Martinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expressionElizabeth Mayne, Nicholas T Funderburg, Scott F Sieg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2013
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapyNicholas T Funderburg, Ying Jiang, Sara M Debanne, et al.
Pageof 31

Showing results (101-110 of 303) with videos related to

Sort By:
Pageof 31
Antiviral Therapy|October 15, 2016
Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacityNicholas T Funderburg, Dihua Xu, Martin P Playford, et al.
AIDS Research and Therapy|April 14, 2005
Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimenHeather A Baird, Andre J Marozsan, Michael M Lederman, et al.
AIDS (London, England)|May 11, 2002
HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigensHernan Valdez, Nicole L Carlson, Anthony B Post, et al.
Pediatric Research|January 20, 2012
Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurityMaricruz Crespo, Denise G Martinez, Adam Cerissi, et al.
The Journal of Infectious Diseases|January 9, 2018
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral TherapyKonstantia Angelidou, Peter W Hunt, Alan L Landay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infectionDonald D Anthony, Nicole L Yonkers, Anthony B Post, et al.
Blood|October 24, 2002
Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxicDong Zhang, Premlata Shankar, Zhan Xu, et al.
Clinical Immunology (Orlando, Fla.)|November 15, 2008
The effect of aging on T-regulatory cell frequency in HIV infectionAllan R Tenorio, John Spritzler, Jeffrey Martinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expressionElizabeth Mayne, Nicholas T Funderburg, Scott F Sieg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2013
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapyNicholas T Funderburg, Ying Jiang, Sara M Debanne, et al.
Pageof 31